BDMD
Baird Medical Investment Holdings Ltd Ordinary Share
Surgical & Medical Instruments & Apparatus
Best Medical Devices Stocks 2026 →
BDMD Stock Analysis: Buy, Sell, or Hold?
$0.11
+0.00 (+3.17%)
▲
5d:
-31.87%
30d:
-80.51%
90d:
-90.5%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (80%)
Quality Score
42/100
Position
OVERSOLD
30-Day Fair Range
$0.15 – $0.66
Position: OVERSOLD
Forward P/E & Valuation
0.8x
CHEAP
vs 4.8x historical avg
Wall Street Target
$4.00
+3627.9% upside
Options IV & Volume
MODERATE Vol
MODERATE volume confirmation
Support / Resistance
$0.07 / $0.27
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: BDMD is down 31.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When BDMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: BDMD is currently trading at $0.11, which is considered oversold relative to its 30-day fair value range of $0.15 to $0.66. From a valuation perspective, the stock is trading at a discount (Forward PE: 0.8) compared to its historical average (4.8). Remarkably, the market is currently pricing in an annual earnings decline of 45.7% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, BDMD is in a strong downtrend. Immediate support is located at $0.07, while resistance sits at $0.27. The stock is showing strong short-term momentum, up 3.2% recently.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $4.00 (+3627.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BDMD is in a strong downtrend. Immediate support is located at $0.07, while resistance sits at $0.27. The stock is showing strong short-term momentum, up 3.2% recently.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $4.00 (+3627.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.15 -
$0.66
Company Quality Score
42/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
79.5%
Trading Range & Key Levels
30-Day Trading Range
$0.15 -
$0.66
Current vs Trading Range
OVERSOLD
Support Level
$0.07
Resistance Level
$0.27
Current Trend
Strong Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (50/100)
- BULLISH: Strong upward momentum (+3.2%)
- BULLISH: Trading 3627.9% below Wall St target ($4.00)
- WARNING: Composite score 42/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
0.77
Wall Street Target
$4.00
(+3627.9%)
Revenue Growth (YoY)
24.6%
Earnings Growth (YoY)
-0.3%
Profit Margin
-65.1%
Valuation Discount vs History
-45.7% cheaper
PE vs Historical
0.8 vs 4.8
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-45.7%
(market-implied from PE analysis)
1-Year Target
$0.10
(-10%)
2-Year Target
$0.09
(-19%)
3-Year Target
$0.08
(-27%)
3-Yr Target (if PE normalizes)
(PE: 1→5)
$0.49
(+357%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 75.0%)
$9.38
(+8645%)
Base:
(SPY PE: 0.8, Growth: 75.0%)
$0.36
(+238%)
Bear:
(PE: 0.7, Growth: 75.0%)
$0.31
(+187%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 0.8 to 4.8
Stabilization Target:
$0.67
(+526.3%)
PE Expansion Potential:
+526.3%
Share BDMD Analysis
Share this live BDMD analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (BDMD)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 13, 2026
Daily AI digest
AI Retail Discussion Summary:
Baird Medical enters South Korea market through a distribution partnership with ALLIS MED, making ALLIS MED the exclusive distributor of Baird Medical's Microwave Ablation products once certified.
Key Retail Themes:
Global expansion
Market entry
Strategic partnership
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 4:39 AM ET
Data refreshes hourly during market hours. Next update: 5:39 AM
Data refreshes hourly during market hours. Next update: 5:39 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BDMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$98 | 54 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
30 analysts |
$340 | 45 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$119 | 48 HOLD |
|
BSX
Boston Scientific Corp |
BUY
31 analysts |
$50 | 51 HOLD |
|
EW
Edwards Lifesciences Corp |
STRONG BUY
30 analysts |
$112 | 33 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive BDMD Research Pages